Event: 24th Annual Needham Virtual Healthcare Conference Dates: April 7-10, 2025 Oncocyte Fireside Chat: April 7, 2025, 3:45 PM (ET) Location: Virtual For more information about Oncocyte and its ...

StockNews.com initiated coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report published on Monday morning. The firm issued a sell rating on the stock. OCX has been the topic of a ...

EDT OncoCyte (OCX) files to sell 10.61M shares of common stock for holdersDon't Miss Our End of Quarter Offers: Discover the latest ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

Fintel reports that on March 28, 2025, Lake Street initiated coverage of OncoCyte (NasdaqCM:OCX) with a Buy recommendation.

Q4 2024 Earnings Call Transcript March 24, 2025 OncoCyte Corporation misses on earnings expectations. Reported EPS is ...

Lake Street 分析师认为，OncoCyte 目前的市场估值并未反映公司的潜力，表明当前股价为长期投资者提供了一个有吸引力的入场点。该公司启动覆盖并给予"买入"评级和5美元的目标价是基于这些因素，表明对 OncoCyte 未来表现的信心。随着公司下一次财报将于4月4日发布，投资者可以通过 InvestingPro ...

Discover OncoCyte's Q4 2024 progress with its cutting-edge kidney transplant test. Insights on FDA ambitions, market strategies & financial runway.